SIXTH AMENDED AND RESTATED CREDIT AGREEMENT Dated as of February 3, 2020 among INTEGRA LIFESCIENCES HOLDINGS CORPORATION, a Delaware corporation, as the Borrower, BANK OF AMERICA, N.A., as Administrative Agent and as the Swing Line Lender and an L/C...Credit Agreement • February 3rd, 2020 • Integra Lifesciences Holdings Corp • Surgical & medical instruments & apparatus • New York
Contract Type FiledFebruary 3rd, 2020 Company Industry JurisdictionThis SIXTH AMENDED AND RESTATED CREDIT AGREEMENT is entered into as of February 3, 2020, among INTEGRA LIFESCIENCES HOLDINGS CORPORATION, a Delaware corporation (the “Borrower”), each lender and issuing bank from time to time party hereto (collectively, the “Lenders” and individually, a “Lender”), BANK OF AMERICA, N.A., as Administrative Agent and as the Swing Line Lender.
RATIFICATION AGREEMENTRatification Agreement • February 3rd, 2020 • Integra Lifesciences Holdings Corp • Surgical & medical instruments & apparatus
Contract Type FiledFebruary 3rd, 2020 Company IndustryRATIFICATION AGREEMENT dated as of February 3, 2020 (as amended, supplemented or otherwise modified from time to time, this “Ratification Agreement”), among Integra LifeSciences Holdings Corporation, a Delaware corporation (the “Borrower”), the subsidiaries identified on the signature pages hereto (together with the Borrower, the “Reaffirming Parties”) and Bank of America, N.A., as administrative agent and collateral agent under the Credit Agreement referred to below (in such capacity, including any successor thereto, the “Administrative Agent”). Terms defined in the Credit Agreement (as defined below) and not otherwise defined herein have, as used herein, the respective meanings provided for therein.